NCT06942689

Determination of the Optimal Volume of Liposomal Bupivacaine in Adductor Canal Block for Knee Joint Surgery

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2025-06-01Est. Completion: 2027-12-31

Enrollment target: 80 participants

Locations

Contact

Total Knee AnthroplastyNerve BlockRopivacaineLiposomal Bupivacaine

Effective postoperative pain management remains a cornerstone of enhanced recovery protocols following total knee arthro…

Wuhan, ChinaEst. completion Sep 4, 2026

Pain and Diaphragmatic Dysfunction After Shoulder Arthroscopy

This study aims to evaluate whether 15ml/75mg low-dose bupivacaine liposome is non-inferior to 15ml/133mg standard-dose …

Jiaxing, ChinaCompleted Sep 1, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.